Aiming for 2020 Pharmaceutical Opportunities Start with optimizing market access architecture?

Wenin the context of the weak profits of medicine, the epidemic caused the pharmaceutical industry to make matters worse, "survival of the fittest" will be fully presentedIn order to survive, enterprises are forced to optimize the access structure, promote enterprises to quickly adapt to the changing environment, find vitalityIn the operation business, market access is the key link, to undertake research and development and marketing, market access success is related to product life cycle managementeach pharmaceutical company has set up market access departments, different definitions, functions are different1General lying domestic drug companies market access department presentscentral government affairs, regional government affairs, responsible for bidding, pricing, central government affairs, regional government affairs, a director with several managers, director issued 60-80 million / year, the general salary of managers is 20-30million / year2In the, enterprise market access is more important, more subdivided, in order to adapt to the environment, need to be continuously optimized:(1) central government affairs team, butt health insurance, health, nDRC, industry and information departments, generally responsible for drug collection, medical insurance catalog, medical and health services, basic drug circulation and national policy analysis and forecastingAmong them, the National Policy and Analysis team is most important in analyzing China's access environment, developing access strategies, action plans, policy trend forecasts, and communicating China policy changes to global headquarters(2) access business team, docking marketing system, responsible for the marketing system of product access strategy, with the head of the business unit and the marketing department to communicate the feasibility of the business unit access strategy(3) local access strategy team, docking with the provinces health, health insurance related departmentsResponsible for the landing of central access strategy and the formulation of regional market access strategy(4) MAO Team," the access strategy operations team responsible for access strategy innovation, access project design, new product pricing, and pharmacoeconomics, is the most operational team The specialization is high, and the threshold for product pricing and pharmacoeconomics is higher than the general access function 1 Central government affairs team job opportunities: (1) health insurance team: "basic medical insurance drug management interim measures" will be released, there may be the following changes: in which the medical insurance catalog adjusted to once a year, while accepting enterprise declarations, bidding access is also a bright spot, a few words, worthy of the central government affairs team in-depth study, for enterprises to strive for access opportunities In particular, the access strategy of central government affairs needs to be highly consistent with the management of health care (2) National Collection Team: with the expansion of the scope of national collection, the increase in price reduction, the impact on enterprises is more significant On April 23, 2020, CDE published the 28th batch of catalog of generic drug consistency evaluation, and it is inevitable that generic drugs will enter the collection without luck How to delay entry into the collection catalog or actively enter the collection catalog, and how to deal with the introduction of the collection rules will also be an important topic of national collection team research (3) health team: "National Basic Drug Catalog" or will be adjusted, the basic drug types are all included in the medical insurance catalog so that the base drug adds value a lot, in the health and health committee has issued a number of documents, emphasizing the drug use program of 1 x, highlighting the status of the use of basic drugs, the establishment of grade hospital seilife ratio, and at the same time included in the hospital assessment and management In addition, there is also a need to consider an update to the Focus Monitoring Drug Catalog or a second batch of publication (4) Other: opportunities for special drug policies such as rare diseases and drug shortages, as well as access for other sector-related policies 2 Access to business team job opportunities: this part of the work is the most grounded gas, the impact on the business Depending on the policy, combined with the strengths and weaknesses of the enterprise's products, assessing the competitor's possible responses, not only internal team analysis and thinking, but also the need to coordinate with the relevant business unit leadership or marketing department, the most test ingests horizontal communication and collaboration skills For example, "The Opinion severing the reform of the medical security system" pointed out that the exploration of rare disease drug protection mechanism, and for haemophiliacs, we know that a head pharmaceutical product has not yet entered the national health insurance catalog, and the competitive products have been accessed, I believe that this part of the work should not be completed independently, there is also the existence of collective wisdom, this work is worth further exploration 3 Job opportunities for local access strategy teams: the harmonization of pharmaceutical policies, but also the characteristics of regionalization and regional pilot The medical insurance directory will tend to be unified in the future, and the policy of collection and collection has the trend of regionalization For example, Hainan Provincial Medical Security Bureau and other four ministries announced the second batch of collection program, pointed out that ,"in the procurement cycle has completed the completion of the amount, the remaining amount may be in accordance with the relevant provisions of centralized procurement management of drugs in our province, the appropriate amount of procurement of other varieties of the same varieties of suitable prices, but in principle, the use of selected drugs is not lower than the amount of non-selected drugs procurement." "This part leaves some opportunities for the local access team the pharmaceutical industry to move forward, the more in the front end, the more in the long-term, high importance, destructive force; The clinical research layout in the research and development pipeline affects the development of enterprises for five to ten years or more, and the loss is in the billions or even billions if the pipeline layout loses Hengrui, the day clear of the outburst is not a day's work the end of the sale, on the current quarter, this year's earnings have an impact, do not do well may be local or a pipeline, but not to the pharmaceutical companies to hurt the bones Market access is similar to research and development, and the front-end access layout affects the product launch process Market access will drive product launch success, especially with the framework optimized enterprises in the market trend after a full understanding, in the new product marketing process should be done: the trend of development, change and win China's pharmaceutical market is on a continuous trend of change, and unstoppable, enterprises should adapt to the general situation, for new product son-to-market to carry out customized special work, including short-term screening of therapeutic areas and varieties, redefining market access and optimizing market access structure today's Chinese medicine market, "survival of the fittest, changer wins!" "